Nauman v. Array Biopharma Inc

Court

District Court, D. Colorado (D. Colo.)
Official Court Website →

Assigned judge

Kristen L. Mix · 632 cases in index

Docket number

1:17-cv-02848

Cause

15:0078j(b)ss - Stockholder Suit
15 U.S.C. § 78j

Nature of suit

850 Securities, Commodities, Exchange
Alleged violations of federal securities or commodities laws.

Jurisdiction

Federal Question

Jury demand

Plaintiff

Date filed

11/28/2017

Date terminated

03/30/2022

1,327 Securities / Commodities cases in this court are indexed here.

Parties

• plaintiff · Nauman · 21 cases
• defendant · Array BioPharma Inc · 15 cases

Part of a Larger Litigation Pattern

This is one of 16 Securities / Commodities cases in our index naming Array BioPharma Inc — a possible mass-tort or coordinated-litigation cluster.

• Dembitzer v. Array BioPharma Inc
  District Court, D. ColoradoFiled 07/12/2019
• Wescott v. Array BioPharma Inc
  District Court, D. DelawareFiled 07/12/2019
• Guerrero v. Array BioPharma Inc
  District Court, D. ColoradoFiled 07/11/2019
• Groeschel v. Array Biopharma, Inc
  District Court, D. ColoradoFiled 07/08/2019
• Noel v. Array Biopharma Inc
  District Court, D. ColoradoFiled 07/03/2019
• Kent v. Array BioPharma Inc
  District Court, D. DelawareFiled 07/01/2019

About Securities / Commodities Lawsuits

Securities cases involve alleged violations of federal securities or commodities laws — including fraud, misstatements to investors, insider trading, and shareholder class actions brought under the Securities Act and Securities Exchange Act.

Frequently Asked Questions

What is Nauman v. Array Biopharma Inc?

Nauman v. Array Biopharma Inc is a federal securities / commodities lawsuit filed on 11/28/2017 in the District Court, D. Colorado. The case was terminated on 03/30/2022. Securities cases involve alleged violations of federal securities or commodities laws — including fraud, misstatements to investors, insider trading, and shareholder class actions brought under the Securities Act and Securities Exchange Act.

What type of case is this?

It is classified as “Securities / Commodities” under the federal nature-of-suit system. Securities cases involve alleged violations of federal securities or commodities laws — including fraud, misstatements to investors, insider trading, and shareholder class actions brought under the Securities Act and Securities Exchange Act.

What court is the case in?

The case is in the District Court, D. Colorado, docket number 1:17-cv-02848.

When was the case filed?

Nauman v. Array Biopharma Inc was filed on 11/28/2017. It was terminated on 03/30/2022.

What law is the case brought under?

The docket lists the cause as 15 U.S.C. § 78j.